Clinical trials for Photodynamic therapy

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Photodynamic therapy. For all clinical trials, go to clinical trials search

This list shows clinical trials for Photodynamic therapy

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Photodynamic therapy
Title Recruitment status Location
Photographing the Skin During Photodynamic Therapy Recruiting United Kingdom
Vascular Targeted Photodynamic Therapy T1a Renal Tumours Recruiting United Kingdom
Treatment of Primary Breast Cancer Using PDT Recruiting United Kingdom
A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PDT in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia Not Recruiting United Kingdom
Combination therapy of Visudyne, Minocycline, Dexamethasone and Ranibizumab (VIMDER) for the treatment of subfoveal choroidal neovascularisation (CNV) Not Recruiting United Kingdom
A comparison of the clinical efficacies of Intense Pulsed Light (IPL), PhotoDynamic Therapy (PDT) and adapalene in the treatment of mild to moderate acne vulgaris Not Recruiting United Kingdom
A randomised, double-masked phase III study of the efficacy and safety of Avastin® (bevacizumab) intravitreal injections compared to best available therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration Not Recruiting United Kingdom
A 24-month randomized, double-masked, multicenter, phase II study assessing safety and efficacy of verteporfin (Visudyne®) photodynamic therapy administered in conjunction with Lucentis™ versus Lucentis™ monotherapy in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration - MONT BLANC Not Recruiting United Kingdom
Not Recruiting United Kingdom
A Phase 3B/4, randomized, active controlled, double-masked, single dummy, multi-center comparative trial, in parallel groups, to compare the safety and efficacy of intravitreous injections of Macugen® given every 6 weeks for up to 102 weeks, plus sham photodynamic therapy (PDT) to Macugen® plus PDT with Visudyne® in subjects with predominantly classic subfoveal choroidal neovascularization (CNV) secondary to Age-Related Macular Degeneration (AMD). - N/A Not Recruiting United Kingdom

Page last reviewed:

Next review due: